Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q86TM3 (
cage
)
29,987
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study is focused on the characterization of interactions of valinomycin (Val), a macrocyclic dodecadepsipeptide antibiotic ionophore, with rubidium cation, Rb(+). Capillary affinity electrophoresis was employed for the experimental evaluation of the strength of the Val-Rb(+) complex. The study involved the measurement of the change of effective electrophoretic mobility of Val at increasing concentration of Rb(+) cation in the BGE. From the dependence of Val effective electrophoretic mobility on the Rb(+) cation concentration in the BGE (methanolic solution of 100 mM Tris, 50 mM acetic acid, 0-1 mM
RbCl
), the apparent binding (stability) constant (K(b)) of the Val-Rb(+) complex in methanol was evaluated as log K(b)=4.63+/-0.27. According to the quantum mechanical density functional theory calculations employed to predict the most probable structure of Val-Rb(+) complex, Val is stabilized by strong non-covalent bond interactions of Rb(+) with six ester carbonyl oxygen atoms so that the position of the "central" Rb(+) cation in the Val
cage
is symmetric.
...
PMID:Capillary electrophoretic and computational study of the complexation of valinomycin with rubidium cation. 1919 4
With the flourishing development of (CH
3
NH
3
)PbI
3
, three-dimensional (3D) organic-inorganic perovskites with unique structure-property flexibility have become a worldwide focus. However, they still face great challenges in effectively inducing ferroelectricity. Despite the typical 3D perovskite structure and the ability of dabco (1,4-diazabicyclo[2.2.2]octane) to trigger phase transition, unfortunately [H
2
dabco]
RbCl
3
adopts a nonpolar crystal structure without ferroelectricity. Within the larger RbI
3
framework, we assemble N-methyl-1,4-diazoniabicyclo[2.2.2]octane (MeHdabco) obtained by reducing the molecular symmetry of dabco into a new 3D organic-inorganic perovskite. As expected, MeHdabco bearing a molecular dipole moment turns out to be vital in the generation of polar crystal structure and ferroelectric phase transition occurring at 430 K. It is the first time that the dabco component has been successfully wrapped into a 3D
cage
to achieve ferroelectricity even through there is intensive research on dabco. This precise molecular design strategy based on the modification of molecular symmetry provides an efficient route to enrich the family of 3D organic-inorganic perovskite ferroelectrics. Intriguingly, the iodine-doped crystal can exhibit intense saffron yellow luminescence with a high quantum yield of 17.17% under UV excitation, extending its application in the field of ferroelectric luminescence and/or multifunctional devices.
...
PMID:Precise Molecular Design of High-T
c
3D Organic-Inorganic Perovskite Ferroelectric: [MeHdabco]RbI
3
(MeHdabco = N-Methyl-1,4-diazoniabicyclo[2.2.2]octane). 2871 92
